Nobel Biocare is committed to thoroughly researching, testing, and documenting its products and solutions for safety and efficacy, before and after launching. This commitment is evidenced by a minimum of one-year clinical follow-up data and documented results, from:
Clinical studies
• multi-center
• randomized controlled
Mechanical testing
• fatigue strength
• torque tolerance
Pre-launch activities
• postmarketing surveillance
• clinician questionnaires
• advisory board review
clinical studies
Currently, Nobel Biocare is running three prospective multicenter studies to validate the survival rates, bone remodeling, and soft tissue maintenance of NobelActive™ implants:
1. Five-year randomized controlled prospective multi-center study began April 2006; final patient included May 2007(1)
• 12 centers throughout Europe
• 177 patients
• 199 NobelActive™ implants
• 126 NobelReplace™ Tapered implants (as control)
• Immediate Function™ in healed sites
Click here to read more (PDF, 0.03 MB)
2. A three-year multi-center; patient inclusion began Feb 2007 and ended Oct 2007(2)
• 7 centers in the US
• 68 patients
• 79 NobelActive™ implants
• Immediate placement and immediate loading in extraction sites
3. A three-year multi-center; patient inclusion began Nov 2007 and is ongoing(3)
• 6 centers in the US
• 60 patients
• Immediate placement and immediate loading in extraction sites